Immuno 2025
April 2025 | London, UK
A two-day event packed with leading speakers, research and cutting-edge presentations on the latest advancements in the discovery & development of cancer immunotherapies.
Explore Immuno 2025: Unlocking Future Insights in Immuno Research
Join 400+ leaders, experts and researchers at Immuno 2025, connecting pharmaceutical & biotech representatives as well as academia for high-level discussions on the latest innovations in immune-oncology discovery & therapeutics development. Immuno 2025 features our ever popular 10th Annual Advances in Immuno-Oncology Congress is attended by over 400 senior level attendees in London to network, debate and discuss the industry’s pressing challenges & opportunities; fostering partnerships & collaborations in the field. Do not miss out on attending these events to stay at the forefront of the latest advancements pushing the immune-oncology industry forward – from the discovery & development of cell & gene, antibody & combination therapies, through to the utilisation of omics techniques and technologies in IO as well as novel target identification & validation strategies. New to the agenda is the introduction of the Innovation & Collaboration track showcasing emerging biotechs & pioneering academic spin off entering the market.
Immuno 2025
- Gain a forward-looking perspective on the opportunities and challenges impacting market growth in immuno-oncology. Our congress brings together immuno-oncology experts across five tracks to provide a comprehensive look at the key trends in this industry, from therapeutic strategies and modelling through to the latest clinical data.
- Discuss the latest innovations in novel targets & target validation in immuno-oncology. Presentations will delve into AI-based approaches for target identification & validation; new technological approaches such as screening and CRISPR and new modalities approaches.
- Examine the latest challenges and technological innovations in preclinical development with discussions on animal modelling techniques and screening strategies along with key, preclinical considerations to drive successful entry into the clinical phase.
Agenda at a Glance
10th Annual Advances in Immuno-Oncology Congress
- Day One | Track 1: Immunotherapy Strategies
- Day One | Track 2: Microbiome & the Gut-Immune Axis
- Day One | Track 3: Discovery & Development: Cell & Gene and Combination Therapies
- Day One | Track 4: Biomarkers, Precision Medicine & Multi-Omics In Immuno-Oncology
- Day One | Track 5: IO Clinical Trials: Design, Data-Management & Case Studies
- Day Two | Track 1: New Clinical Development for Immunotherapies
- Day Two | Track 2: Manufacturing Novel Products at Scale
- Day Two | Track 3: Discovery & Development: Antibody Therapies
- Day Two | Track 4: Predictive Models & Tools for Preclinical Evaluation and Translational Development
- Day Two | Track 5: Novel Targets in Immuno-oncology: Identification, Validation & Exploration
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences
-
Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
-
Global Technological Showcase
An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field. -
Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections -
Innovative Poster Displays
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions
Companies Represented Include
Meet Our Expert Speakers
The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at Immuno 2024: 25 - 26 April 2024, London, UK
All Speakers
Meet Our Esteemed Sponsors
Sponsors of Immuno 2024 included
Interested in Sponsoring?
Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.
Learn moreLatest Resources
First Patient Dosed with NK Cell Therapy for the Treatment of an Autoimmune Disease, Lupus Nephritis
Positive Results from iNKT Cell Therapy Clinical Trial for COVID-19 ARDS
Bispecific T Cell Engagers and Synthetic Immunity: Circumventing Immune Escape
Patients Enter Clinic for Phase III mRNA Immunotherapy for High Risk Melanoma
How to Improve Therapeutic Efficacy: Safety Considerations in Oncolytic Virotherapy
Zika Virus Tested as an Effective Oncolytic Agent for Glioblastoma in In Vitro Models
Register Your Interest
Submit your details and a member of our team will be in touch